Toxicity |
484 |
Treatment |
485 |
Concluding remarks and future | |
directions |
485 |
References |
486 |
Introduction |
487 |
Background |
487 |
Pharmacokinetics / toxicokinetics |
488 |
Mechanism of action |
488 |
Toxicity |
489 |
Treatment |
490 |
Concluding remarks and future | |
directions |
490 |
References |
490 |
Chronic toxicity |
509 |
Tolerance development |
510 |
Concluding remarks and future directions |
510 |
References |
511 |
Steve M. Ensley | |
Introduction |
515 |
Background |
515 |
Pharmacokinetics / toxicokinetics |
516 |
Mechanism of action |
517 |
Toxicity |
517 |
Treatment |
518 |
Concluding remarks and future directions |
518 |
References |
518 |
Introduction |
493 |
Background |
493 |
Pharmacokinetics / toxicokinetics |
493 |
Mechanism of action |
493 |
Toxicity |
494 |
Treatment |
494 |
Concluding remarks and future | |
directions |
495 |
References |
495 |
Introduction |
499 |
Background |
499 |
OP pesticides |
500 |
OP nerve agents / gases |
500 |
Carbamates |
500 |
Pharmacokinetics of OPs and CMs |
500 |
Mechanism of action |
506 |
Toxicity |
507 |
Treatment of acute poisoning |
508 |
OP / CM-induced intermediate | |
syndrome |
509 |
Introduction |
527 |
Background |
528 |
Pharmacokinetics / toxicokinetics |
528 |
Mechanism of action |
528 |
Toxicity |
528 |
Treatment |
529 |
Concluding remarks and future | |
directions |
529 |
References |
529 |
Introduction |
531 |
Background |
531 |
Pharmacokinetics / toxicokinetics |
531 |
Mechanism of action |
532 |